FDA Plans Thorough Investigation Into BPA Safety In Medical Products
This article was originally published in The Gray Sheet
Executive Summary
FDA's investigation into the safety of the chemical Bisphenol A in medical products will start with a look at cardiopulmonary bypass procedures for children as well as hemodialysis